NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market on Friday that it completed its acquisition of autoimmune diagnostics firm Crescendo Bioscience.
Registering provides access to this and other free content.
Already have an account?Login Now.
Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.
DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.
A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.
In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.